Apex Trader Funding - News
Why Is Life Science-Focused Danaher Trading Higher On Tuesday?
Tuesday, Danaher Corp (NYSE:DHR) said its first-quarter sales decreased 2.5% Y/Y to $5.79 billion, beating the consensus of $5.62 billion.
Non-GAAP core revenue decreased 4%, exceeding expectations of a high-single-digit decline.
Operating cash flow was $1.7 billion, and non-GAAP free cash flow was $1.4 billion.
Rainer Blair, President and CEO, stated, “We had a good start to 2024, with our team delivering better-than-expected revenue, earnings, and cash flow. We were ...